EME BLOOD GAS AND ELECTROLYTE ANALYZERS MARKET ANALYSIS

The EME blood gas and electrolyte analyzer market is estimated to be valued at US$ 159.5 million in 2023 and is expected to exhibit a CAGR of 5.3% during the forecast period (2023-2030).

Analysts’ Views on EME Blood Gas and Electrolyte Analyzer Market:

The market is primarily being driven by the increased prevalence of chronic diseases including cardiovascular diseases (CVD), cancer, etc., and the growing geriatric population. This is to provide a platform that is rapid, efficient sample processing. This influences the market's major companies to prioritize growth tactics like product releases. For instance, on March 22, 2023, Inspira-Technologies OXY B.H.N. LTD., an innovative medical device company specializing in respiratory care solutions announced the first human patient undergoing open-heart surgery in the HYLA research clinical study at Sheba Medical Center, Israel. The HYLA Blood sensor is a non-invasive optical blood sensor, being developed using machine learning-based algorithms to measure blood key parameters, continuously and in real-time during extracorporeal procedures including VV-ECMO, VA-ECMO, and open-heart surgery. The HYLA sensor measurements are designed to alert physicians of sudden changes in a patient’s blood key parameters, as well as alert perfusionists of sudden changes in oxygenator performance and blood recirculation

Figure 1. EME Blood Gas and Electrolyte Analyzer Market Share (%), by Product Type, 2023

To learn more about this report, request sample copy

EME Blood Gas and Electrolyte Analyzer Market– Driver

Increase prevalence of the geriatric population

Increasing incidence of the geriatric population leads to the use of blood gas and electrolyte analyzer which directly increases the need and is expected to boost the growth of the EME blood gas and electrolyte analyzer market over the forecast period. For instance, on March 10, 2023, according to an article published by Nature in the Journal of Scientific Reports, the percentage of persons aged 65 overreached 2.4% of the total population for the year 2020.

Increase in number of product approval

Increase in the number of product approval by regulatory authorities is expected to dominate the market over the forecast period. For instance, in September 2022, Sysmex Corporation, a manufacturer and distributor of in vitro diagnostic instruments launches the UF-1500 Fully Automated Urine Particle Analyzer (UF-1500), a new product for use in urine sediment testing. The UF-1500 inherits the high levels of functionality and usability of the UF-5000 Fully Automated Urine Particle Analyzer (UF-5000), our flagship model in urine sediment testing while achieving a downsizing of the former model. 

Figure 2. EME Blood Gas and Electrolyte Analyzer Market Value (US$ Million), by Region, 2023

To learn more about this report, request sample copy

EME Blood Gas and Electrolyte Analyzer Market- Regional Analysis

Among regions, Europe is estimated to hold a dominant position in the EME blood gas electrolyte analyzer market over the forecast period. Europe is estimated to hold 59.5% of the market share. The Europe blood gas and electrolyte analyzer market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of chronic diseases such as cardiovascular diseases and the increase in the geriatric population. Thus, the rise in EME blood gas and electrolyte analyzer market growth over the forecast period. For instance, in October 2020, it is estimated that an average person in Russia has a 25% risk of dying prematurely (i.e. before the age of 70) from one of the four main NCDs (Noncommunicable diseases) such as cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases and can avert over 4.3 million deaths. 

EME Blood Gas and Electrolyte Analyzer Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the EME blood gas electrolyte analyzer market. The COVID-19 outbreak led to the use of automated CPR devices for reducing the risk factors by providing necessary services to patients. For instance, in June 2022, according to an article published in the Journal of Archivos de Bronconeumología, the occurrence of acute respiratory failure is the most important cause of immediate hospitalization. Up to 20% of COVID-19 patients need intensive care unit (ICU) care, with 30%–100% treated with mechanical ventilation. Mortality of ICU patients ranged from 26% to 61.5%. Among critically ill patients, severe acute hypoxemic respiratory failure is the dominant finding, whereas hypercapnia is rare. So, this increase the need for the EME blood gas and electrolyte analyzer market.

EME Blood Gas and Electrolyte Analyzer Market Segmentation:

The EME blood gas and analyzer market report is segmented into product type, modality, end user, and region.

By Product Type, the EME blood gas and analyzer market is segmented into blood gas analyzers, electrolyte analyzers, combination analyzers, and consumables. Out of which, the blood gas analyzers segment is expected to dominate the EME blood gas and electrolyte market during the forecast period and this is due to the increase in the prevalence of the geriatric population and the increase in chronic diseases.

By Modality, the EME blood gas and analyzer market is segmented into laboratory analyzers, benchtop analyzers, and portable analyzers. The laboratory analyzers segment is expected to dominate the market over the forecast period and this is due to the growing ability to determine the concentration of certain compounds within samples of serum, plasma, urine, and/or other body fluids

By End user, the EME blood gas and analyzer market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and clinics. The hospital segment is expected to dominate the market over the forecast period and this is attributed to the increasing prevalence of chronic diseases and geriatric population.

By Region, the EME blood gas and analyzer market is segmented into Europe and Middle East. Out of which, Europe is expected to dominate the market over the forecast period owing to the increase in the launch of products by market key players.

Among all segmentation, the product segment has the highest potential due to the increasing product launch by the key market players over the forecast period. For instance, in November 2021, Boditech Med Inc., a pharmaceutical company that provides diagnostic solutions launched its immunoassay analyzer AFIAS-10 with blood collection tube, including an all-in-one cartridge system, at MEDICA 2021. 

EME Blood Gas and Electrolyte Analyzer Market Cross Sectional Analysis:

Rising incidence of cardiovascular diseases and the increasing geriatric population is expected to boost demand for the EME blood gas and electrolyte analyzer market in Europe. For instance, in February 2022, according to an article published in the Journal of European Heart Journal, each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. CVD causes 45% of all deaths in Europe and 37% in the EU (European Union).

EME Blood Gas and Electrolyte Analyzer Market: Key Developments

In July 2022, Inspira Technologies OXY B.H.N. Ltd., a respiratory support technology company, revealed the development of the HYLA blood sensor. Without the need to take actual blood samples from patients, Inspira Technologies OXY B.H.N. Ltd's non-invasive optical blood sensor is being designed to perform real-time and continuous blood monitoring to alert physicians of immediate signs of changes in a patient’s clinical condition.

On January 18, 2023, Koninklijke Philips N.V., a global company in health technology, and Masimo, a global medical technology company, announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with the Masimo W1 advanced health tracking watch. The W1 will integrate with Koninklijke Philips N.V. enterprise patient monitoring ecosystem to advance the forefront of telemonitoring and telehealth.

In January 2021, ENVEA, a global manufacturer of ambient, emission, and process monitoring systems, presents its new portable multi-gas monitor MIR 9000P designed to meet the specific needs of regulatory and periodic MIR 9000P is compliant with international directives and standards such as the United States Environmental Protection Agency and EN 15267-4, the latest European standards for Portable Automatic Measurement Systems. It guarantees high accuracy and extended measuring ranges for 8 parameters (NOx, SO2, CO, CO2, CH4, N2O, O2, and residual H2O).

In April 2022, Inspira Technologies OXY B.H.N. Ltd., a respiratory support technology company announced the execution of a summary distribution agreement with Bepex International LLC., a Medical Equipment Manufacturing, Medical Devices & Equipment, and -Intensive Care company that includes the potential future deployment of Inspira Technologies OXY B.H.N. Ltd., ART (Augmented Respiration Technology) systems, designed to prevent the need for invasive mechanical ventilation. As part of the collaboration with Bepex International LLC., the first systems are slated for deployment at the largest medical centers in Israel.

EME Blood Gas and Electrolyte Analyzer Market: Key Trends

Increasing initiatives by governmental bodies for diagnostic tools

The use and significance of devices are being widely disseminated throughout society and the state by several governmental organizations and major industry participants in the blood gas analyzer market. These steps taken by the market participants and the government are assisting the users in reaching out to benefit from the laws created for low-income and developing countries that inform people of ailments that, if detected early enough, are avoidable. Due to the rising incidence of chronic diseases in the country and increased government initiatives, the use of blood gas analyzers in hospitals and emergency departments is highly promoted. For instance, in July 2022, according to the International Trade Administration, in the 2022 federal budget, a total of US$ 15.8 billion (AED 58.931 billion) was approved for public spending out of which 8.4% is dedicated to healthcare. The UAE government endeavors to utilize greater data monitoring tools for preemptive COVID contact tracing and to license virtual medical service providers. The government also plans to build national capacities to fight future pandemics which include efforts to develop vaccines and medicines, digital immunization IDs, and a new strategy focusing on supply chains.

EME Blood Gas and Electrolyte Analyzer Market: Restraint

High costs of blood gas and electrolyte analyzer

High costs of blood gas and electrolyte analyzer are slated to hinder market expansion. Due to the high cost of blood gas and electrolyte analyzer, it produces high chances of shifting from blood gas and electrolytes analyzer to electrolyte analyzer which will lead to less efficacy as compared to blood gas and electrolyte analyzer, which indirectly hinder the growth of the EME blood gas electrolyte analyzer market. So, the use of a simple electrolyte analyzer to be carried out to avoid the higher cost of blood gas and electrolyte analyzer For instance, in May 2022, according to an article published in the Journal of Annals of Medicine and Surgery, the average cost of blood gas and electrolyte the average cost of Hematology Analyzer is US$ 7314.36 which is much higher for the patients.

EME Blood Gas and Electrolyte Analyzer Market - Key Players

Major players operating in the EME blood gas and electrolyte market include Abbott, Medica Corporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, EKF Diagnostics, ERBA Diagnostics Mannheim GmbH, Inspira-Technologies OXY B.H.N. LTD. and Werfen.

*Definition: Blood gas analyzers are used to measure combinations of pH, blood gas (i.e. pCO2 and pO2), electrolytes, and metabolites parameters from whole blood samples. Blood conservation is an important initiative in every clinical diagnostic lab or critical care facility. An electrolyte analyzer is a device that measures electrolytes in the human body. They are mostly used to quantify salt, potassium, and chloride levels in whole blood, serum, or plasma.